Chiesi USA, Inc. — Trimbow (beclomethasone/formoterol/glycopyrrolate)
for maintenance treatment of asthma
FDA approved Trimbow (beclomethasone/formoterol/glycopyrrolate) inhaler for maintenance treatment of asthma.
for maintenance treatment of asthma
FDA approved Trimbow (beclomethasone/formoterol/glycopyrrolate) inhaler for maintenance treatment of asthma.
Asthma is a long-term inflammatory disease of the airways that causes recurring wheezing, coughing, chest tightness, and shortness of breath, and can flare into attacks when allergens or dust are inhaled and the airways narrow and fill with mucus. Trimbow is an inhaler that delivers three medicines at once: a steroid that calms airway inflammation, plus two bronchodilators that relax tightened airway muscles and keep the breathing passages open. Together these actions may help people with asthma breathe more easily and reduce how often symptoms flare.
Primary objective The primary objective was to evaluate the efficacy of a free combination of CHF 5259 at 3 dose levels plus Foster® 100/6 μg in a pMDI by comparison with Foster® 100/6 μg in terms of forced expiratory volume in the first second (FEV1) area under the curve between time 0 and 12 hours (AUC0-12h) normalised by time on Day 42. Key secondary objective The key secondary objective was to evaluate the efficacy of the free combination CHF 5259 plus Foster® 100/6 μg by comparison wit...
Source: ClinicalTrials.gov